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Corrects CINChromosomal instability is a driving force for heterogeneity within tumours.
A recent study shows that boosting sister chromatid cohesion corrects
chromosomal instability in pRB-deficient cancer cells. This key finding
provides an important lead to make tumours more susceptible to anti-cancer
drugs.Ahmed M.O. Elbatsh,
Rene´ H. Medema,
and Benjamin D. Rowland*
We have known for over a century that
cancer cells often have chromosome
numbers that deviate strongly from the
healthy diploid karyotype. The German
pathologist David Hansemann already
noted back in 1890 that, even within a
given tumour, some nuclei contain
more chromatin than others [1]. We
now know that this phenotype of
chromosomal instability (CIN) can be
found in many cancer types and is
particularly abundant in solid tumours.
CIN tumours are notoriously difficult
to treat with anti-cancer drugs.
The continuous gain and loss of
chromosomes in these tumour cells
is thought to be the driver for
intra-tumour heterogeneity. This
unstable karyotype facilitates the
accelerated evolution of cancer cells
such that they can easily adapt to
evade the action of chemotherapeutic
agents [2].
CIN is caused by errors in the
segregation of chromosomes in
mitosis. Chromosome segregation is
controlled by an intricate cellular
network, which ensures that each of
the daughter cells inherits a complete
copy of the genome. A key aspect ofthis network is sister chromatid
cohesion, which is mediated by the
cohesin complex. Cohesin is believed
to entrap both sister chromatids of
each individual chromosome inside its
ring-shaped structure. Cohesin holds
together the sister chromatids until the
moment that all chromosomes are
correctly attached to microtubules
from both poles of the cell. Then the
sudden destruction of cohesin allows
the synchronous separation of the
sister chromatids to the opposite
poles. This process is tightly
controlled, as premature loss of
cohesion leads to segregation errors
and to daughter cells with unequal
karyotypes [3].
It is therefore perhaps not surprising
that the cohesin complex is often found
to be mutated in CIN tumours [4]. An
important example is the finding that
mutations in cohesin’s STAG2 subunit
are causative for the CIN phenotype of
glioblastoma cells [5]. Cohesion is also
affected by inactivation of the pRB
tumour suppressor pathway. pRB
inactivation leads to defects in sister
chromatid cohesion and to segregation
errors in mitosis, which in turn cause
chromosomal instability [6,7]. Loss of
pRB or its upstream regulator p16ink4a
is a common feature of many human
cancers [8]. pRB inactivation maythereby represent a common cause
of CIN in a large portion of human
cancers.
The CIN phenotype of tumours in
essence creates two therapeutic
possibilities. The first option is to
augment the chromosome segregation
defect such that the degree of the
errors is no longer compatible with
survival of the cancer cells. A
potential drawback of this approach
is that healthy cells will likely
undergo segregation defects due to
this treatment, which is dangerous by
itself. A fundamentally different
approach is to correct the
segregation defects of CIN tumours.
This treatment will not kill cancer cells
directly, but it would slow down
intra-tumour evolution. This could be
beneficial to prevent the development
of resistance to chemotherapeutic
agents.
An important new study from the
Dyson laboratory [9] now shows that
the segregation errors caused by
pRB inactivation can be corrected by
boosting sister chromatid cohesion.
How pRB regulates cohesion is not
fully understood, but it appears
to involve the Suv4-20H2
methyltransferase. pRB binds to
this factor that is important for
the recruitment of cohesin to
heterochromatin [10,11]. Indeed, the
segregation errors of pRB-deficient
cells can be corrected
by overexpression of Suv4-20H2.
Importantly, the cohesion defect and
the segregation errors can also be
corrected by inactivation of cohesin’s
antagonist Wapl [9]. In the absence
of Wapl, cohesin rings more stably
associate with DNA [12]. The new
paper goes on to show that
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Figure 1. Restoring cohesion corrects chromosomal instability in pRB-deficient cells.
(A) pRB-deficient cells display cohesion defects that cause segregation errors and chromo-
somal instability (CIN). The continuous gain and loss of chromosomes of CIN cells can underlie
subclonal diversity within tumours. This heterogeneity is thought to be a major cause for the
emergence of drug resistance upon treatment. (B) Restoring sister chromatid cohesion
corrects chromosome segregation errors in pRB-deficient cells. Suppression of CIN reduces
intra-tumour heterogeneity, which could render tumours more susceptible to treatment with
anti-cancer drugs.
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R572inactivation of Wapl even corrects
the chromosomal instability of
non-small cell lung cancer cells in
which the pRB pathway iscompromised by either loss of pRB
or loss of p16ink4a, or by CDK4
amplification (Figure 1) [9]. This is a
crucial finding that may have majorconsequences. If it were possible to
stabilise the karyotype within CIN
tumours, this would indeed be very
valuable and this paper suggests that
targeting Wapl might be one way to
achieve this feat.
The new study interestingly also
touches upon a current topic of
debate [13–15]. Ultimately, CIN is the
consequence of incorrect separation
of chromosomes in mitosis, but this
defect does not necessarily need to be
caused by faults in the chromosome
segregation machinery. In fact, CIN
was recently shown to often be the
consequence of errors in DNA
replication [13]. Many cancer cells
suffer from a decrease in replication
speed that is referred to as ‘replication
stress’. This can lead to DNA segments
that remain unreplicated, even though
the cells progress from S phase to
mitosis. Unreplicated DNA fragments
in turn can cause segregation errors, as
both chromatids of one chromosome
stay connected by one stretch of
DNA. The CIN phenotype can
therefore be the consequence of
either defects in S phase or errors in
mitosis.
Replication stress can be caused
by nucleotide insufficiency as a
consequence of unscheduled S phase
entry. In correspondence with earlier
work, the new paper shows that pRB
inactivation leads to such replication
stress, and that this defect can be
rescued by supplementing the cells
with exogenous nucleosides [9,16].
Unexpectedly, however, nucleoside
addition also rescues the cohesion
defect and the segregation errors of
pRB-deficient cells. Perhaps even
more remarkably, the replication
stress of pRB-deficient cells is
also rescued by the depletion of
Wapl [9]. Inactivation of Wapl
apparently rescues both the cohesion
defects and the replication defects
that are observed upon pRB
inactivation.
These findings raise many questions
on the precise mechanisms involved.
How Wapl may affect DNA replication
is unknown. This activity does
appear to be conserved through
evolution, as a recent paper has
shown that Wapl-deficient budding
yeast also display an increase in
replication speed [17]. It will also be
important to further dissect whether
the replication stress is a
consequence of the cohesion defect,
or vice versa. Cohesin stably holds
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R573together the sister DNAs of each
chromosome from S phase until
mitosis. This paper underscores how
poorly we actually understand the
interconnections between DNA
replication and the establishment of
cohesion.
But irrespective of the mechanism,
this paper suggests that both
nucleoside supplementation and
Wapl inactivation might be valid
approaches to correct the CIN
phenotype of pRB-deficient tumours.
Nucleoside supplementation may
carry significant risk, as elevated
dNTP levels can lead to increased
cellular mutation rates [18]. Targeting
Wapl for anti-cancer therapy may also
not be without risk, as Wapl
inactivation in healthy cells causes
segregation defects by itself. However,
Wapl depletion causes a
p53-dependent cell-cycle arrest in
non-cancerous cells, which should
protect healthy cells against the
adverse consequences of Wapl
inactivation. Wapl loss in healthy cells
leads to unwanted cohesin on
chromosome arms in mitosis, whereas
its inactivation in pRB-deficient
cells appears to restore cohesion
levels to a basal state that is
optimal for proper chromosome
segregation [9,19,20].
Wapl has no known enzymatic
activity, so it will not be straightforward
to target Wapl with a drug. Also,
how Wapl antagonises cohesin
complexes is largely a mystery. It
will therefore be important to further
elucidate the cellular pathways by
which Wapl regulates cohesion in
order to uncover other players in this
pathway that may be better drug
targets. Such a drug could be highly
beneficial as adjuvant therapy to
prevent the resistance of CIN tumours
to a primary drug that specifically
targets the cancer cells.
We have learned a lot about
chromosomal instability since
Hansemann’s pioneering work of the
1890s. This new paper [9] now provides
us with important new insight into the
cause of CIN, and at the same time
pinpoints potential therapeutic targets
for counteracting CIN. Important
discoveries often open up many
possibilities for future studies, and
this paper is clearly no exception.
Both fundamental scientists and
translational researchers now have
plenty of newquestions that arewaiting
to be answered.References
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The discovery of novel T helper cell
subsets — Th17, Th9, Th22, regulatory
and follicular helper T cells — thatextended Mosmann’s Th1/Th2
paradigm was accompanied by an
explosion of research into the
mechanisms that control T helper cell
differentiation. In a similar way, the
recent description of distinct innate
